Literature DB >> 7814512

Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR.

M Maass1, K Dalhoff.   

Abstract

Amplification inhibitors can lead to false-negative results for PCR. In order to evaluate the reliability of PCR for the detection of Chlamydia pneumoniae, the presence of PCR inhibitors in 75 bronchoalveolar lavage specimens was assessed after treatment by various sample preparation methods. Specimens were collected from patients with acute respiratory infections, including four cases of proven C. pneumoniae infection. Substances inhibitory to the amplification of chlamydial DNA continued to be present in 12% of the samples treated according to the commonly used single-step proteinase K digestion and in 31% of the samples processed by heat treatment. However, the complexing of DNA-contaminating proteins and polysaccharides from digested specimens to cetyltrimethylammonium bromide (CTAB) followed by DNA extraction efficiently removed inhibitors from all experimental samples and provided subsequent identification of all positive clinical samples by PCR. The CTAB method and proteinase K treatment had comparable detection limits of approximately 0.01 inclusion-forming units. CTAB-based DNA purification of respiratory specimens is recommended to increase the diagnostic sensitivity of PCR and confidence in negative results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814512      PMCID: PMC264119          DOI: 10.1128/jcm.32.10.2616-2619.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Identification of a new group of Chlamydia psittaci strains called TWAR.

Authors:  C C Kuo; H H Chen; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

3.  A potent inhibitor of Taq polymerase copurifies with human genomic DNA.

Authors:  R de Franchis; N C Cross; N S Foulkes; T M Cox
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

4.  Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification.

Authors:  S M Holland; C A Gaydos; T C Quinn
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

5.  Growth in serum-free medium improves isolation of Chlamydia pneumoniae.

Authors:  M Maass; A Essig; R Marre; W Henkel
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

6.  Infection with Chlamydia pneumoniae in Brooklyn.

Authors:  K Chirgwin; P M Roblin; M Gelling; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

7.  Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract.

Authors:  K H Wong; S K Skelton; Y K Chan
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Detection of Chlamydia pneumoniae by polymerase chain reaction.

Authors:  L A Campbell; M Perez Melgosa; D J Hamilton; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene.

Authors:  C A Gaydos; T C Quinn; J J Eiden
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

10.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Authors:  A Shor; C C Kuo; D L Patton
Journal:  S Afr Med J       Date:  1992-09
View more
  13 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay.

Authors:  Jens Gieffers; Robert J Belland; William Whitmire; Scot Ouellette; Deborah Crane; Matthias Maass; Gerald I Byrne; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  Comparison of sample preparation methods for detection of Legionella pneumophila in culture-positive bronchoalveolar lavage fluids by PCR.

Authors:  B Jaulhac; M Reyrolle; Y K Sodahlon; S Jarraud; M Kubina; H Monteil; Y Piémont; J Etienne
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

4.  Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain.

Authors:  R H Ring; J M Lyons
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 5.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Transport and storage conditions for cultural recovery of Chlamydia pneumoniae.

Authors:  M Maass; K Dalhoff
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

7.  Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction.

Authors:  J G Kuipers; L Nietfeld; U Dreses-Werringloer; L Koehler; J Wollenhaupt; H Zeidler; M Hammer
Journal:  Ann Rheum Dis       Date:  1999-02       Impact factor: 19.103

Review 8.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 9.  Low occurrence of pathogenic Yersinia enterocolitica in clinical, food, and environmental samples: a methodological problem.

Authors:  Maria Fredriksson-Ahomaa; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Detection of Mycoplasma hyopneumoniae in bronchoalveolar lavage fluids of pigs by PCR.

Authors:  A K Baumeister; M Runge; M Ganter; A A Feenstra; F Delbeck; H Kirchhoff
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.